Skip to main content

"Forget software, the real opportunity is in exporting healthcare"

Are Indian companies going to be able to provide enough jobs for the increasing millions of young Indians that are going to graduate each year? If not, the oft spoken about "demographic dividend" is likely to turn out to be more of a "demographic curse".

In this context, Businessworld has an interesting article pointing out that the big opportunity in exporting healthcare workers from India to more advanced whose populations are ageing fast healthcare costs are zooming.
As critics of the demographic dividend thesis point out, the focus is all on the supply of labour, while very little is said about demand. Admittedly, the additional supply of labour does offer the potential for employment and growth. But there is no guarantee that demand would match supply and lead to more jobs and production. The fact is, India will have to provide employment for 15 million job entrants every year and not 10 million as estimated earlier. “We haven’t done even 10 million yet,” points out Debroy. One concern here is that nearly half of India reports itself as self-employed and this is not just in agriculture. “Therefore, we shouldn’t think in terms of employer-employee relationships alone; we need to look at skills, access to credit, land markets, healthcare, physical connectivity (roads, power).”

On the other side are experts who believe that the demographically dying countries of Europe (Germany, Italy, Russia) offer India a great opportunity to export labour. The ageing population of Europe means there will be tremendous demand for healthcare workers, from doctors, nurses and attendants. In 20 years, the world will be swamped by people of over 80 years, and this will be a huge chance for Indians if we provide them with the proper skills, says eminent demographer Ashish Bose, honorary professor, Institute of Economic Growth, Delhi, and member of the National Commission on Population.

...Bose, who leads the optimists brigade, says we need a more energetic policy to tap the potential. “Forget software,” he says. “Train our young people in healthcare. Give them a crash course in languages. The next quarter century is ours because India is a demographic giant.”

Elsewhere in the same issue of Businessworld, a column titled "Better Red Than Dead" by Kenneth Rogoff, a Harvard Professor of Economics and Public Policy and former IMF chief economist, shows how desperately the West needs to lower healthcare costs. He forecasts that the inexorable rise in medical costs will in the near future test the "moral, social and political support for capitalism".
Rising incomes, population ageing and new technologies for enhancing life have caused health costs to rise 3.5 per cent faster than overall income for many decades now in the US. Some leading economists project that health expenditures, which now constitute 16 per cent of the US economy, will rise to 30 per cent of GDP by 2030, and perhaps approach 50 per cent later in the century. Countries in Europe and elsewhere have shielded their citizens from a part of this rise by piggybacking on US technological advances. Ultimately, though, they face the same upward cost pressures.

...Many societies view healthcare as a right, not a luxury. When medical expenses constituted only a small percentage of income, as was typically the case 50 years ago, an egalitarian approach to healthcare was a small extravagance. The direct and indirect costs were relatively minor and affordable.

But as health expenses start taking up a third of national income, healthcare socialism starts becoming just plain Marxism: to each according to his needs. Even China’s authoritarion capitalism will someday feel the pressure, as its rural populations, who currently have little access to doctors or hospitals, eventually explode with discontent.




Arun Natarajan is the Founder & CEO of Venture Intelligence, the leading provider of information and networking services to the private equity and venture capital ecosystem in India. View free samples of Venture Intelligence newsletters and reports.

Popular posts from this blog

PE-VC investments in Q2'23 decline 33% to $9.9 Billion

Private Equity-Venture Capital (PE-VC) investments in India during the quarter ended June 2023 (Q2'23), at $9.85 Billion across 182 deals, registered a 33% decrease compared to the same period in 2022 (which saw $14.6 Billion being invested across 371 deals). The investment amount however rose 74% compared to the immediate previous quarter (which saw $5.7 Billion being invested across 181 deals), shows data from  Venture Intelligence , a research service focused on private company financials, transactions, and their valuations. The PE-VC investment figures for the first 6 months of 2023 - at $15.5 Billion (across 363 deals) - was 50% lower compared to the same period in 2022 (which saw $31 Billion being invested across 800 deals). Q2’23 witnessed 19 mega deals ($100 M+

Chiratae, Speciale and Stride Ventures win APEX'24 Venture Capital Awards

Chiratae Ventures, Speciale Invest and Stride Ventures were awarded as among the leading Venture Capital investors in India for 2023 as part of Venture Intelligence APEX‘24 Private Equity & Venture Capital awards event in Mumbai.  The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms and "crowd sourced" voting from the Limited Partner, PE-VC and advisory communities. (The main criteria are Return Track Record, New Fund Raises & Follow-on Funding Rounds for Portfolio Companies) VC Investor of the Year Chiratae Ventures received the Venture Capital Investor of the Year 2023 Award on the back of 10 part exits totaling $178 million via Secondary Sales during the year. Its exits included those from retail unicorn Lenskart, SaaS Startup Pixis and baby pr

Blackstone, MO Alts and InvAscent win APEX'24 Private Equity Awards

Press Release Blackstone, MO Alternates (formerly Motilal Oswal PE) and InvAscent were awarded as among the leading Private Equity and Growth Capital investors in India for 2023 as part of Venture Intelligence APEX‘24 Private Equity & Venture Capital awards event in Mumbai.  The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer. The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms and "crowd sourced" voting from the Limited Partner, PE-VC and advisory communities. (The main criteria are Return Track Record, New Fund Raises & Follow-on Funding Rounds for Portfolio Companies) PE Investor of the Year Blackstone received the Private Equity Investor of the Year 2023 Award on the back of strong complete exits during the year: from Sona Comstar and IBS Software. Ganesh Mani and Amit Dalmia, Senior Managing D

Avendus tops League Table for Transaction Advisors to PE deals in Q1'23

Aeka Advisors and Ambit claim the No.2 & 3 slot Avendus topped the Venture Intelligence League Table for Transaction Advisor to Private Equity Transactions for Q1 2023 advising 5 deals worth $808 million. Aeka Advisors stood second having advised 3 deals worth $228 million. Ambit followed with 4 deals worth $160 million. Ernst & Young ($114 million across 4 deals) and o3 Capital ($80 million across 2 deals) completed the top five for Q1 2023. Avendus acted as advisor to ADIA’s $500 million investment in omnichannel eyewear retailer Lenskart . Aeka Advisors acted as advisor to Kreditbee’s $160 million fundraise from Advent International, Mitsubishi UFJ Financial Group (MUFG) and existing investors. Ambit advised the $104 million fundraise of Freshtohome from Mount Judi Ventures, Iron Pillar, Amazon and others. The  Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on the value of PE

PE-VC investments fall 38% in 2023 to below $30 B

The value of investments by Private Equity - Venture Capital (PE-VC) firms in India fell by 38% to less than $30 Billion in 2023. PE-VC firms invested $29.7 Billion (across 756 deals) in Indian companies in 2023, compared to $47.6 Billion (across 1,362 deals) in the previous year, reports Venture Intelligenc e, a research service focused on private company financials, transactions, and their valuations. (Note: These figures exclude PE investments in Real Estate).                                                                                                                                                                      2023 witnessed 67 mega deals ($100 M+ rounds) worth $21.2 Billion, compared to 112 such investments worth $31.8 Billion in 2022. The $2.4 Billion investment in Manipal Hospitals by Temasek (which gained majority control) and TPG Capital was the largest PE-VC investment in 2023. This was followed by the $1.35 Billion buyout of education loans focused HDFC Credila